Entera Bio to Present at 2022 Maxim Virtual Growth Conference
BOSTON and JERUSALEM, March 22, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
News
Aligos Discontinues Development of its Antisense Oligonucleotide Drug Candidate ALG-020572 in Subjects with Chronic Hepatitis B and Pivots Internal Strategic Emphasis to its Small Molecule Portfolio
Dosing in the first cohort discontinued after multiple reports of ALT flares suggestive of drug-induced…
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
Cauley to Lead Development of Company’s Proprietary DNA Data Storage Technology SAN DIEGO, March 22,…
CORRECTION — Statera Biopharma Announces Proposed Underwritten Public Offering
FORT COLLINS, Colo., March 22, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan
LAVAL, Québec, March 22, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Windtree Announces Results from Its Phase 2 Study of Lucinactant for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) and Lung Injury
Results support the feasibility for development of a potential treatment for critically ill patients with…
Decibel Therapeutics to Participate in Upcoming Investor Conferences
BOSTON, March 22, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
CDR-Life to Present at the American Association for Cancer Research 2022 Annual Meeting
ZÜRICH, Switzerland, March 22, 2022 (GLOBE NEWSWIRE) — CDR-Life Inc., a biotechnology company pioneering a…
Adamis Pharmaceuticals Announces Results of Tempol in Omicron Virus Challenge in Hamster Model
Tempol Reduced Lung Inflammation After High Dose Challenge SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE)…
Voyager Therapeutics Appoints Alfred W. Sandrock, Jr., M.D., Ph.D., as Chief Executive Officer
Renowned neuroscientist brings pioneering drug development expertise and vision to emerging leader in next-generation AAV…
First Wave BioPharma to Participate in Maxim’s 2022 Virtual Growth Conference
BOCA RATON, Fla., March 22, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI),…
Matinas BioPharma to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
BEDMINSTER, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage…
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2021 Financial Results
BERKELEY HEIGHTS, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:…
Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit
DEVON, Pa., March 22, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
ProMIS Neurosciences Presents Preclinical Results of its Experimental Alzheimer’s Vaccine at the 2022 International AD/PDTM Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
Customized vaccine selectively targets toxic amyloid-beta oligomers TORONTO, Ontario and CAMBRIDGE, Mass., March 22, 2022…
On the cutting edge! motorola edge+ 5G UW makes its way to Verizon on March 24
BASKING RIDGE, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Looking for a slick new 5G…
Verizon Business Introduces BlueJeans Meetings for Corporate Learning and Training
What you need to know: Empowering online instructors to create an effective learning environment, BlueJeans…
GTT Launches Secure Connect to Enhance Enterprise Cloud Security
GTT Secure Connect offering leverages the SASE (Secure Access Service Edge) framework, augmenting GTT’s portfolio…
AvePoint Advances Information Lifecycle Management Capabilities
Updates to Cloud Records help to swiftly manage critical information and business data, and ensure…
ibex Receives Four 2022 CUSTOMER Magazine Product of the Year Awards
ibex Wave X, RefleCX, Training Simulator, and Social Reputation Management Honored for Exceptional Innovation ibex…